This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Assessment of the Type I IFN Response in the Nasal Cavity During Respiratory Viral Infections in a Geriatric Department | MicrobiomeTrials

NCT07601412

Assessment of the Type I IFN Response in the Nasal Cavity During Respiratory Viral Infections in a Geriatric Department

RecruitingOBSERVATIONAL

Trial Details

Start: 2024-01-04Est. Completion: 2026-05-31

Enrollment target: 1,140 participants

Locations

Contact

SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome

The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…

Alcalá de Henares, SpainEst. completion Oct 2, 2026

Covid19

Conducting an initial small, controlled clinical pharmacology trial to assess for therapeutic biologics activity (proof-…

North Bethesda, United StatesEst. completion Nov 18, 2026

Respiratory Tract InfectionSmell DisorderInfluenzaRhinosinusitisCOVID-19DepressionParosmiaHyposomiaNormosomiaAnosmia

Background: Loss of the sense of smell can seriously affect a person's quality of life. The ability to smell can be dam…

Bethesda, United StatesEst. completion Sep 30, 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.